Wordt geladen...
In vivo liposomal delivery of PPARα/γ dual agonist tesaglitazar in a model of obesity enriches macrophage targeting and limits liver and kidney drug effects
Macrophages are important regulators of obesity-associated inflammation and PPARα and -γ agonism in macrophages has anti-inflammatory effects. In this study, we tested the efficacy with which liposomal delivery could target the PPARα/γ dual agonist tesaglitazar to macrophages while reducing drug act...
Bewaard in:
| Gepubliceerd in: | Theranostics |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Ivyspring International Publisher
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6929996/ https://ncbi.nlm.nih.gov/pubmed/31903139 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.36572 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|